Sylvia Wagner

Title: Sylvia Wagner: Innovator in Nanoparticle Carrier Systems

Introduction

Sylvia Wagner is a prominent inventor based in Neunkirchen, Germany. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of nanoparticle carrier systems for photodynamic therapy. Her innovative work focuses on enhancing the efficacy and safety of photosensitizers used in medical treatments.

Latest Patents

Wagner holds a patent for "Nanoparticle carrier systems based on human serum albumin for photodynamic therapy." This invention provides compositions that are stable in storage and outlines a method for producing pharmaceutical-based nanoparticulate formulations. These formulations incorporate a hydrophobic photosensitizer, human serum albumin (HSA), and a stabilizing agent. The nanoparticulate formulations are designed to deliver therapeutically effective amounts of photosensitizer for parenteral administration. Notably, tetrapyrrole derivatives can be utilized as photosensitizers, with their efficacy and safety enhanced through these formulations. The patent also details a method for preparing HSA-based nanoparticles under sterile conditions, with a preferred embodiment involving temoporfin as a hydrophobic photosensitizer for treating hyperplastic and neoplastic conditions, particularly targeting tumor cells.

Career Highlights

Throughout her career, Sylvia Wagner has worked with notable companies in the pharmaceutical sector, including Biolitec Pharma Marketing Ltd and Biolitec Holding GmbH & Co. KG. Her experience in these organizations has contributed to her expertise in developing innovative therapeutic solutions.

Collaborations

Wagner has collaborated with esteemed colleagues, including Klaus Langer and Matthias Wacker. These partnerships have furthered her research and development efforts in the field of nanoparticle technology.

Conclusion

Sylvia Wagner's contributions to the field of nanoparticle carrier systems exemplify her dedication to advancing medical therapies. Her innovative patent and collaborative efforts highlight her role as a key figure in pharmaceutical research and development.